Stock Movers: Broadcom, Coinbase, Humana (Podcast)

Broadcom shares plunged after its AI-chip sales outlook disappointed investors, triggering a rotation out of AI-related tech and a broader Friday selloff. Coinbase fell after Baird turned bearish on weak trading volumes and delayed U.S. crypto legislation, while Humana rose after Morgan Stanley lifted its price target to $249 from $217. The piece highlights a risk-off move across AI, crypto, and parts of the broader market.

Analysis

The market is reacting less to one company’s guide than to the possibility that AI capex is shifting from a straight-line growth story into a lumpy procurement cycle. When one bellwether misses on near-term AI-chip visibility, the first-order selloff is in semis, but the more important second-order effect is on the entire “AI duration” basket: data-center power, networking, foundry utilization, and the higher-multiple software names whose valuations assume uninterrupted infrastructure buildouts. That creates a window where the market may briefly punish beneficiaries more than losers, especially among suppliers whose orders are still project-based rather than recurring.

For crypto, the issue is not just weaker volume; it’s that reduced trading activity compresses operating leverage exactly when regulatory optionality was supposed to support multiple expansion. If legislation slips beyond the mid-term election window, the market may start treating exchange equities like cyclical financials rather than platform assets, which means every 10% deterioration in volumes can translate into a disproportionate cut in forward EBITDA expectations. The risk is that spot crypto softness and equities de-risking reinforce each other, keeping volumes depressed for weeks rather than days.

Healthcare’s relative strength matters because it highlights a defensives bid with idiosyncratic catalysts, not broad sector rotation. If money continues to rotate out of AI-beta into managed care, the next beneficiaries are likely to be names with visible reimbursement, pricing, or earnings revisions—not necessarily the highest-quality operators, but those with the cleanest near-term estimate path. The contrarian read is that the selloff in growth/AI may be more about positioning and crowdedness than fundamental collapse, so a sharp rebound is possible if broader index support holds and guidance revisions stay contained over the next 2-6 weeks.

Key Decisions for Investors

• Short AVGO into any pre-open bounce; tactical 1-3 week trade with tight risk if the market starts to re-price AI demand as a timing issue rather than a demand destruction story. Cover on any evidence of peer stability or a broader semis rebound.
• Pair trade long HUM / short a basket of AI beta names (or SMH) for 2-6 weeks. The goal is to own the lower-duration earnings stream while the market digests capex uncertainty; risk is a fast reversal if semis stabilize and defensives fade.
• Short COIN against a basket of higher-volume crypto proxies only if spot activity remains weak for another 1-2 weeks; otherwise use options, as the stock’s downside is highly sensitive to volume downgrades but can snap back on any crypto rally. Favor put spreads over outright shorts.
• If already long AI infrastructure, hedge with short QQQ or SMH calls expiring 3-6 weeks out. The setup is for further multiple compression if guidance revisions spread, but the hedge should be time-boxed because positioning could mean-revert quickly.
• Watch for a 5-10% retracement in semis as the entry point for quality longs in names with recurring AI revenue; the contrarian opportunity is strongest once forced selling clears, not on the first down day.